Biologist and molecular biotechnologist, with a Master’s degree and ongoing Ph.D. in Genetics and Molecular Biology at the Federal University of Rio Grande do Sul (UFRGS), Brazil. Works in the field of Human and Medical Genetics, with a focus on pharmacogenetics, immunogenetics, population genomics, and complex diseases. Currently conducts doctoral research investigating the association between genetic variants in the APOL1 gene (G1, G2, and p.N264K) and the risk of chronic kidney disease (CKD) in Afro-descendant individuals living with HIV in Southern Brazil. The study aims to understand the genetic susceptibility to CKD in this population and to address health disparities through a precision medicine approach. Participates in interdisciplinary research projects involving the pharmacogenomics of thalidomide, immunogenetics of leprosy, COVID-19 susceptibility, and the molecular mechanisms of drug-induced teratogenesis. Experienced in bioinformatics, transcriptomic data analysis, variant interpretation, and the integration of clinical and genomic data. Main research interests include personalized medicine, population genetics, neglected diseases, and health equity among Afro-descendant populations.